Both IL-17 and Th17 cells have been ascribed tumor promoting as well as tumor suppressing functions. immunohistochemistry.30 A final potential risk factor was observed in a study of leukemia patients treated with allogeneic stem cell transplantation after myeloablative conditioning, which included donors that varied from related to unrelated and different prophylaxis regimens to prevent graft-vs.-host… Continue reading Both IL-17 and Th17 cells have been ascribed tumor promoting as